Results for “”

Entry Author Date Location
Stoke Therapeutics Preps IPO to Bring Dravet Syndrome Drug to Clinic 05/24/19 Boston
Second US Gene Therapy, Approved for Rare Muscle Disease, to Cost $2M 05/24/19 National
Boston Tech Watch: Robin, Markforged, Air Force AI & CozyKin 05/24/19 Boston
Bio Roundup: Zolgensma Watch, Brain Cancer Blues, Peloton Payout & More 05/24/19 National
Ideaya and Bicycle Therapeutics IPOs Raise $110M for Cancer Drug R&D 05/23/19 San Francisco
With $120M, AlloVir Faces Big Test of Cell Therapy to Fight Infection 05/22/19 Texas
Sebastian Thrun and Udacity Launch New Self-Driving Nanodegree 05/21/19 San Francisco
Guardicore Raises $60M and Moves US HQ to Boston From San Francisco 05/21/19 Boston
Nomination Deadline Extended for Xconomy Awards Boston 05/20/19 Boston
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More 05/17/19 National
Boston Tech Watch: Hydrow, Sea Machines, Toast, Pillar & More 05/17/19 Boston
ASCO Abstracts: Breast Cancer, Precision Treatments in the Spotlight 05/16/19 National
Laurie Glimcher To Headline Xconomy Keynote Series in Boston in September 05/16/19 Boston
Pillar Fuels Second Go-Round With $100M Fund for Boston Startups 05/16/19 Boston
Ginkgo Eyes Antibiotics With Deal for Warp Drive’s Gene “Mining” Tech 05/15/19 Boston
Vertex Continues Plan to Diversify, Strikes a $70M Pact With Kymera 05/15/19 Boston
Endpoint Security Company CrowdStrike Files Publicly for IPO 05/14/19 San Francisco
Stock, Profit & AI: Carbon Black CEO Reviews Year Since IPO 05/13/19 Boston
ElevateBio Gets $150M to Grow a Crop of Gene & Cell Therapy Startups 05/13/19 Boston
Register Today and Save on “What’s Hot in Boston Biotech” on May 21 05/10/19 Boston
Bio Roundup: Rare Disease Showdowns, Prices on TV, Dealmania & More 05/10/19 National
Boston Tech Watch: MIT Solves, AltioStar Raises & Enel Scouts 05/10/19 Boston
Uber Completes $8.1B Public Market Debut in Spite of Tumultuous Past 05/09/19 San Francisco
Two Days, Five Biotech IPOs, and $359M Raised for Clinical Trials 05/09/19 National
Nominations for Xconomy Awards Boston Ending Soon 05/09/19 Boston
Goldfinch Bio Lands $55M From Gilead in Kidney Drug R&D Pact 05/08/19 Boston
SMA, Migraine Data Lead Neuro Highlights from AAN Meeting 05/07/19 National
Verve Has Top Cardio-Geneticist, $58.5M to Aim CRISPR at Heart Attacks 05/07/19 Boston
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea 05/06/19 New York
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More 05/03/19 National
Page 1 of 127 next page »